🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Denileukin diftitox may be able to deliver cancer-killing substa...
Status
Completed
Location
Veterans Affairs Medical Center - Miami
Start Date
1999-11
Trial ID
NCT00006345
Treatments Being Tested
This is a Phase 1, open-label, multi-center, competitive enrollment, and do...
Status
Recruiting
Location
James A. Haley Veterans' Hospital
Start Date
2025-08-16
Trial ID
NCT07049328
Treatments Being Tested
The study is a randomized Phase II, four arm treatment trial. The primary p...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2005-09
Trial ID
NCT00224874
Treatments Being Tested
This study tests whether denileukin diftitox will deplete regulatory T cell...
Status
Completed
Location
CTRC at UTHSCSA
Start Date
2007-02
Trial ID
NCT00880360
Treatments Being Tested
This is an open-label, clinical efficacy study of Ipilimumab in patients wi...
Status
Terminated
Location
James Graham Brown Cancer Center
Start Date
2012-01
Trial ID
NCT02009384
Treatments Being Tested
RATIONALE: Combinations of biological substances in denileukin diftitox may...
Status
Completed
Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Start Date
2005-09
Trial ID
NCT00128622
RATIONALE: Biological therapies, such as hu14.18-interleukin-2 fusion prote...
Status
Completed
Location
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Start Date
2005-05
Trial ID
NCT00109863
Treatments Being Tested
In this study the investigators investigate a cell therapy strategy that co...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2010-08
Trial ID
NCT01181258
Treatments Being Tested
This phase I trial studies the safety and the ability to expand laboratory-...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2003-06
Trial ID
NCT00228358
This study examines the use of denileukin diftitox (Ontak) for patients wit...
Status
Terminated
Location
Washington University
Start Date
2008-07-01
Trial ID
NCT00632827